| Financial Year |
March 31 2023 |
| Monetary Funds |
122,572,011.55 |
| Held-for-trading Financial Assets |
13,076,600.00 |
| Notes Receivable |
64,035,482.98 |
| Accounts Receivable |
591,799,339.84 |
| Advances to Suppliers |
40,956,052.05 |
| Other Receivables |
39,577,900.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
359,252,249.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
64,159,565.34 |
| Other Current Assets |
38,488,921.41 |
| Total Current Assets |
1,352,742,427.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
59,492,546.42 |
| Long-term Equity Investment |
31,570,738.43 |
| Investment Properties |
51,311,725.58 |
| Fixed Assetes |
160,675,530.84 |
| Under-construction Projects |
233,628.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
435,506,963.68 |
| R&D expenses |
-- |
| Goodwill |
30,038,218.23 |
| Long-Term Deferred and Prepaid Expenses |
1,107,004.07 |
| Deferred Income Tax Assets |
51,280,479.05 |
| Other Non-Current Assets |
26,185,262.56 |
| Sub-Total of Non-Current Assets |
850,456,882.74 |
| Total Assets |
2,203,199,309.92 |
| Short-Term Loans |
309,315,994.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
74,535,996.09 |
| Accounts Payable |
460,329,940.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,228,237.79 |
| Taxes Payable |
4,097,621.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
141,155,757.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,846,933.11 |
| Other Current Liabilities |
105,145,054.69 |
| Sub-Total of Current Liabilities |
1,254,294,734.20 |
| Long-term Loans |
182,879,662.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,182,962.60 |
| Deferred Income Tax Liabilities |
13,521,332.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
215,556,274.43 |
| Total Liabilities |
1,469,851,008.63 |
| Paid-In Capital(Or Share Stock) |
440,487,994.00 |
| Capital Surplus |
96,840,741.76 |
| Surplus Reserve |
29,282,946.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
50,216,229.52 |
| Minority Stockholder's Interest |
111,435,496.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
621,912,804.61 |
| Owner's Equity（Stockholder's Equity） |
733,348,301.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,203,199,309.92 |
